Kellogg's leadership team from top left: David Antonetti, Ph.D., Jill Bixler, M.D., Wayne Cornblath, M.D., Sherry Day, O.D., FAAO, Angela Elam, M.D., Christopher Gappy, M.D., Catherine Huebner, COA, B.S., Thiran Jayasundera, M.D., Denise John, M.D., FRCSC, Shannon Joseph, M.D., M.Sc, Ariane Kaplan, M.D., Shahzad Mian, M.D., Paula Anne Newman-Casey, M.D., M.S., Perry Schechtman, B.S., M.P.P., Roni Shtein, M.D., M.S., Joshua Stein, M.D., M.S., Jennifer Weizer, M.D., Maria Woodward, M.D., M.S.
• Our development of groundbreaking new biomedical tools, such as a minimally-invasive ‘nanoneedle’ platform for painless, sustained intraocular drug delivery, and photo-mediated ultrasound- a potentially safer, more precise method of removing tiny retinal blood vessels. • The grant-funded work of Kellogg’s basic, clinical and translational researchers to identify new therapeutic targets for conditions including choroideremia, nanophthalmos, inherited retinal degenerations, and proliferative vitreoretinopathy. • Faculty dedicated to eliminating disparities in visual health, including the development and implementation of a personal-
The Chair’s Perspective Dear Friends and Colleagues, “She made it clear they would not stop until they figured it out.” That’s how a patient profiled in this report recounts the relentless determination of his Kellogg opththalmologist and her colleagues from across Michigan Medicine to decode his perplexing symptoms in order to provide life-saving treatment.
ized intervention among residents of Detroit. • Kellogg’s sustained commitment to training tomorrow’s ophthalmology leaders in wide-ranging areas such as a new neural engineering training program in Ann Arbor, an NIHfunded program to train eye disease researchers in India, and a pediatric ophthalmology fellowship in Ghana. • Kellogg alumni and supporters who are critical partners in our success, providing expertise, wisdom and resources for our efforts. Throughout the challenges of this past year and a half,
Every day our Kellogg physicians, residents, fellows and staff
the resiliency, tenacity, and hard work of everyone at Kellogg
work to earn our reputation as a team that never backs down
has been central to our continuing success. We are grateful for
from ophthalmology’s challenges.
the opportunity we have every day to improve the lives of our
In this year’s Annual Report, we share stories that highlight how our guiding principles of innovation, teamwork, inclusion,
patients, communities, and our Kellogg teammates. We thank you for your encouragement and support.
caring, and integrity direct our care and shape our commitment to creating tomorrow’s new treatments, including: • Expanded treatment options, from living donor corneal limbal stem cell transplants to over 50 active clinical trials and more.
Paul P. Lee, M.D., J.D. F. Bruce Fralick Professor and Chair, Ophthalmology and Visual Sciences Director, W.K. Kellogg Eye Center 1
